News
At the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema (RAVE) Conference in Chicago, Illinois, the crowd-favorite “Battle of the Two Titans” debate returned to discuss which patients are contenders for systemic therapies and the steps needed to make that decision
This interview with Silverberg featured a discussion of new data on systemic therapies for various dermatologic conditions.
Jonathan Silverberg, MD, PhD, MPH, shares insights into the change of this year’s meeting and the benefit of additional disease states.
Professor of dermatology, Adam Friedman, MD commented on the rise of fake versions of #botox and how to distinguish it from the real thing via LosAngelesTimes
Dr. Adam Friedman, professor and Chair of dermatology at the George Washington University School of Medicine and Health Sciences joined WTOP to debunk some of these myths and tell us what we can all do to try and prevent skin cancer.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision making is, why it is important in dermatology, as well as common challenging scenarios where shared decision making is particularly important to consider in the older…
Cutaneous oncologist Vishal Patel sees the world from very different planes: with an interest in global health, he has a big-picture view of the impacts of skin cancer, and as a renowned Mohs micrographic surgeon, his perspective is very granular. In between, he’s a husband and dad who loves…
Newswise — Rosacea, a common and disabling skin condition, affects 10 percent of the population worldwide. Symptoms of the chronic inflammatory skin disease may be persistent, and triggered by daily exposures like sun and heat.
Professor and Chair of Dermatology at George Washington University Dr. Adam Friedman joined Fox 5 with daughter Daphne to share some tips on keeping your skin safe this summer.
Dr. Friedman spoke in this interview segment on improvements that have been made and improvements that he believes are needed to affect change regarding atopic dermatitis treatment disparities.